Current Neurology and Neuroscience Reports

, Volume 1, Issue 1, pp 54–66

Stroke in young adults and children

  • Birgitte H. Bendixen
  • Jerahme Posner
  • Richard Lango


Data from studies of 337 children and 1606 young adults are summarized to identify the major causes of stroke in these age groups. In children under 15 years of age, stroke occurs in patients with congenital heart disease, nonatherosclerotic vasculopathies, infection, and hematologic defects like sickle cell disease. In patients 15 to 35 years of age, dissection, cardioembolism, nonatheroslerotic vasculopathies, and prothrombotic states cause a significant percentage of strokes. In adults over 35 years of age, traditional atherosclerotic risk factors predominate. Lifestyle choices (eg, cigarette smoking, alcohol consumption, and illicit drug use) can significantly increase the rate of stroke among young adults in a community. Limited access to healthcare may increase the role of infectious disease and peripartum complications.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Rozenthul-Sorokin N, Ronen R, Tamir A, et al.: Stroke in the young in Israel. Stroke 1996, 27:838–841.PubMedGoogle Scholar
  2. 2.
    Kittner SJ, McCarter RJ, Sherwin R, et al.: Black-white differences in stroke risk among young adults. Stroke 1993, 24:I13-I15.PubMedGoogle Scholar
  3. 3.
    Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250–255.PubMedGoogle Scholar
  4. 4.
    Ferrera PC, Curran CB, Swanson H: Etiology of pediatric ischemic stroke. Am J Emerg Med 1997, 15:671–679.PubMedCrossRefGoogle Scholar
  5. 5.
    Bevan H, Sharma K, Bradley W: Stroke in young adults. Stroke 1990, 21:382–386.PubMedGoogle Scholar
  6. 6.
    Taylor TN, Davis PH, Torner JC, et al.: Lifetime cost of stroke in the United States. Stroke 1996, 27:1459–1466.PubMedGoogle Scholar
  7. 7.
    Kerr LM, Anderson DM, Thompson JA, Lyver SM: Ischemic stroke in the young: evaluation and age comparison of patients six months to thirty-nine years. J Child Neurol 1993, 8:266–270.PubMedGoogle Scholar
  8. 8.
    Kittner SJ, Stern BJ, Wozniak MA, et al.: Cerebral infarction in young adults. Neurology 1998, 50:890–894.PubMedGoogle Scholar
  9. 9.
    Williams LS, Garg BP, Cohen M, et al.: Subtypes of ischemic stroke in children and young adults. Neurology 1997, 49:1541–1545. One of the more thoughtful series on strokes in young adults and children.PubMedGoogle Scholar
  10. 10.
    Barinagarrementeria F, Gonzalez-Duarte A, Miranda L, Cantu C: Cerebral infarction in young women: analysis of 130 cases. Eur Neurol 1998, 40:228–233.PubMedCrossRefGoogle Scholar
  11. 11.
    Neto JS, Santos AC, Fabio SC, Sakamoto AC: Cerebral infarction in patients aged 15 to 40 years. Stroke 1996, 27:2016–2019.Google Scholar
  12. 12.
    You RX, McNeil JJ, O’Malley HM, et al.: Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997, 28:1913–1918.PubMedGoogle Scholar
  13. 13.
    Lanzino G, Andreoli A, DiPasquale G, et al.: Etiopathogenesis and prognosis of cerebral ischemia in young adults. A survey of 155 treated patients. Acta Neurol Scand 1991, 84:321–325.PubMedGoogle Scholar
  14. 14.
    Awada A: Stroke in Saudi Arabian young adults: a study of 120 cases. Acta Neurol Scand 1994, 89:323–328.PubMedCrossRefGoogle Scholar
  15. 15.
    Koul R, Motta A, Razdan S: Epidemiology of young strokes in rural Kashmir, India. Acta Neurol Scand 1990, 82:1–3.PubMedGoogle Scholar
  16. 16.
    Kwon SU, Kim JS, Lee MC: Ischemic stroke in Korean young adults. Acta Neurol Scand 2000, 101:19–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Riikonen R, Santavuori P: Hereditary and acquired risk factors for childhood stroke. Neuropediatrics 1994, 227–233.Google Scholar
  18. 18.
    Mancini J, Girard N, Chabrol B, et al.: Ischemic cerebrovascular disease in children: retrospective study of 35 patients. J Child Neurol 1997, 12:193–199.PubMedGoogle Scholar
  19. 19.
    Giroud M, Lemesle M, Madinier G, et al.: Stroke in children under 16 years of age. Clinical and etiological difference with adults. Acta Neurol Scand 1997, 96:401–406.PubMedCrossRefGoogle Scholar
  20. 20.
    Al-Sulaiman A, Bademosi O, Ismail H, Magboll G: Stroke in Saudi children. J Child Neurol 1999, 14:295–298.PubMedGoogle Scholar
  21. 21.
    Nagaraja D, Verma A, Taly AB, et al.: Cerebrovascular disease in children. Acta Neurol Scand 1994, 90:251–255.PubMedCrossRefGoogle Scholar
  22. 22.
    Kristensen B, Malm J, Carlberg B, et al.: Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997, 28:1702–1709.PubMedGoogle Scholar
  23. 23.
    Petitti DB, Sidney S, Quesenberry C, Bernstein A: Stroke and cocaine or amphetamine use. Epidemiology 1998, 9:596–600.PubMedCrossRefGoogle Scholar
  24. 24.
    Sloan MA, Kittner SJ, Feeser BR, et al.: Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology 1998, 19:1688–1693.Google Scholar
  25. 25.
    Kunst AE, del Rios M, Groenhof F, Mackenback JP, and European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in stroke mortality among middle-aged men. An international overview. Stroke 1998, 29:2285–2291.PubMedGoogle Scholar
  26. 26.
    Casper M, Wing S, Strogatz D, et al.: Antihypertensive treatment and US trends in stroke mortality, 1962 to 1980. Am J Public Health 2000, 82:1600–1606.Google Scholar
  27. 27.
    Sacco RL, Boden-Albala B, Gan R, et al.: Stroke incidence among white, black, and Hispanic residents of an urban community. Am J Epidemiol 1998, 147:259–268.PubMedGoogle Scholar
  28. 28.
    Gillum RF: Stroke mortality in blacks. Stroke 1999, 30:1711–1715.PubMedGoogle Scholar
  29. 29.
    Stewart JA, Dundas R, Howard RS, et al.: Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ 1999, 318:967–971.PubMedGoogle Scholar
  30. 30.
    Kirkham FJ: Stroke in childhood. Arch Dis Child 1999, 81:85–89.PubMedGoogle Scholar
  31. 31.
    Lidegaard O, Soe M, Andersen MV: Cerebral thromboembolism among young women and men in Denmark 1977–1982. Stroke 1986, 17:670–675.PubMedGoogle Scholar
  32. 32.
    Masuda J, Ogata J, Yamaguchi T: Moyamoya disease. In In Stroke Pathophysiology, Diagnosis, and Management, edn 3. Edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM. New York: Churchill Livingstone; 1998:815–832. A very lucid and comprehensive review of Moyamoya.Google Scholar
  33. 33.
    Guillon B, Levy C, Bousser MG: Internal carotid artery dissection: an update. J Neurol Sci 1998, 153:146–158.PubMedCrossRefGoogle Scholar
  34. 34.
    Chang AJ, Mylonakis E, Karanasias P, et al.: Spontaneous bilateral vertebral artery dissections: case report and literature review. Mayo Clin Proc 1999, 74:893–896.PubMedGoogle Scholar
  35. 35.
    Barinagarrementeria F, Amaya LE, Cantu C: Causes and mechanisms of cerebellar infarction in young patients. Stroke 1997, 28:2400–2404.PubMedGoogle Scholar
  36. 36.
    Sloan MA, Kittner SJ, Rigamonti D, Price TR: Occurrence of stroke associated with use/abuse of drugs. Neurology 1991, 41:1358–1364.PubMedGoogle Scholar
  37. 37.
    Grau AJ, Buggle F, Hacke W: Infectious diseases as a cause and risk factor for cerebrovascular ischemia. Nervenarzt 1996, 67:639–649.PubMedCrossRefGoogle Scholar
  38. 38.
    Mavrommatis AC, Theodoridis T, Orfanidou A, et al.: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28:451–457.PubMedCrossRefGoogle Scholar
  39. 39.
    Simon RP: Neurosyphilis. Neurology 1994, 44:2228–2229.PubMedGoogle Scholar
  40. 40.
    Tyler KL, Sandberg E, Baum KF: Medial medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology 1994, 44:2231–2235.PubMedGoogle Scholar
  41. 41.
    Fishman RA: CSF findings in diseases of the nervous system. In Cerebrospinal Fluid in Diseases of the Nervous System, edn 2. Edited by Fishman RA. Philadelphia: WB Saunders; 1992:253–344.Google Scholar
  42. 42.
    Case Records of the Massachusetts General Hospital. Case 36-1996. N Engl J Med 2000, 335:1587–1595.Google Scholar
  43. 43.
    Dubrovsky T, Curless R, Scott G, et al.: Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology 1998, 51:560–565.PubMedGoogle Scholar
  44. 44.
    Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al.: Neurologic complications of the reactivation of Varicella-zoster virus. N Engl J Med 2000, 342:635–645.PubMedCrossRefGoogle Scholar
  45. 45.
    Preul MC, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998, 42:971–977.PubMedCrossRefGoogle Scholar
  46. 46.
    Ohene-Frempong K, Weiner SJ, Sleeper LA, and Cooperative Study of Sickle Cell Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288–294.PubMedGoogle Scholar
  47. 47.
    Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease. Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 51:169–176.PubMedGoogle Scholar
  48. 48.
    Kinney TR, Sleeper LA, Wang WC, et al.: Silent cerebral infarcts in sickle cell disease: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999, 103:640–645.PubMedCrossRefGoogle Scholar
  49. 49.
    Armstrong FD, Thompson RJ Jr, Wang W, et al.: Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996, 97:864–870.PubMedGoogle Scholar
  50. 50.
    Nietert PJ, Abboud MR, Silverstein MD, Jackson SM: Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 2000, 95:3057–3064.PubMedGoogle Scholar
  51. 51.
    Ware RE, Zimmerman SA, Schulz WH: Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999, 94:3022–3026.PubMedGoogle Scholar
  52. 52.
    Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5–11. Landmark paper that identifies patients with sickle cell disease who are at high risk for stroke and require immediate intervention.PubMedCrossRefGoogle Scholar
  53. 53.
    DeStefano V, Finazzi G, Mannucci PM: Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 2000, 87:3531–3544.Google Scholar
  54. 54.
    Martinez HR, Rangel-Guerra RA, Marfil LJ: Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993, 24:19–25.PubMedGoogle Scholar
  55. 55.
    Reitsma PH, Bernardi F, Doig RG, et al.: Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Hemost 1995, 73:876–879.Google Scholar
  56. 56.
    Koh S, Chen LS: Protein C and S deficiency in children with ischemic cerebrovascular accident. Pediatr Neurol 1997, 17:319–321.PubMedCrossRefGoogle Scholar
  57. 57.
    Dahlback B: Resistance to activated protein C, the Arg506 to Gln mutation in the Factor V gene, and venous thrombosis. Functional tests and DNA-based assays, Pros and Cons. Thromb Haemost 1995, 73:739–742.PubMedGoogle Scholar
  58. 58.
    Nabavi DG, Junker R, Wolff E, et al.: Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study of 225 patients. J Neurol 1998, 245:653–658.PubMedCrossRefGoogle Scholar
  59. 59.
    Rosendaal FR: Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997, 78:1–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Frenkel EP, Bick RL: Prothrombin G20210A gene mutation, heparin cofactor II defects, primary essential thrombocythemia, and thrombohemorrhagic manifestations. Sem Thromb Hemost 1999, 25:375–386.Google Scholar
  61. 61.
    Brey RL, Hart RG, Sherman DG, Tegeler CH: Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990, 40:1190–1196.PubMedGoogle Scholar
  62. 62.
    Schoning M, Klein R, Krageloh-Mann I, et al.: Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994, 25:8–14.PubMedGoogle Scholar
  63. 63.
    Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988, 8(Suppl 7):1–96.Google Scholar
  64. 64.
    Welch KM, Tatemichi TK, Morh JP: Migraine and stroke. In Stroke Pathophysiology, Diagnosis, and Management, edn 3. Edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM. New York: Churchill Livingstone; 1998:845–867.Google Scholar
  65. 65.
    D’Anglejan-Chatillon J, Ribeiro V, Youl BD, Bousser MG: Migraine—a risk factor for dissection of cervical arteries. Headache 1989, 29:560–561.PubMedCrossRefGoogle Scholar
  66. 66.
    Tzourio C, El Amrani M, Robert L, Alperovitch A: Serum elastase activity is elevated in migraine. Ann Neurol 2000, 47:648–651.PubMedCrossRefGoogle Scholar
  67. 67.
    Solomon S, Lipton RB, Harris PY: Arterial stenosis in migraine: spasm or arteriopathy? Headache 1990, 30:52–61.PubMedCrossRefGoogle Scholar
  68. 68.
    Shuaib A: Stroke from other etiologies masquerading as migraine-stroke. Stroke 1991, 22:1068–1074.PubMedGoogle Scholar
  69. 69.
    Bousser MG, Tournier-Lasserve E: Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19–21, 1993. Stroke 1994, 25:704–707.PubMedGoogle Scholar
  70. 70.
    Ruchoux MM, Chabriat H, Bousser MG, et al.: Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994, 25:2291–2292.PubMedGoogle Scholar
  71. 71.
    Chabriat H, Tournier-Lasserve E, Bousser MG: Vasculopathies. In Genetics of Cerebrovascular Disease. Edited by Alberts MJ. Armonk, NY: Futura Publishing; 1999:195–208. Lucid, comprehensive summary.Google Scholar
  72. 72.
    Hutchison M, O’Riordan J, Javed M, et al.: Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann Neurol 2000, 38:817–824.CrossRefGoogle Scholar
  73. 73.
    Yoo JH, Chung CS, Kang SS: Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998, 29:2478–2483.PubMedGoogle Scholar
  74. 74.
    Kittner SJ, Giles WH, Macko RF, et al.: Homocyst(e)ine and risk of cerebral infarction in a biracial population. The Stroke Prevention in Young Women Study. Stroke 1999, 30:1554–1560.PubMedGoogle Scholar
  75. 75.
    Domagala TB, Undas A, Libura M, Szczeklik A: Pathogenesis of vascular disease in hyperhomocysteinemia. J Cardiovasc Risk 1998, 5:239–247.PubMedCrossRefGoogle Scholar
  76. 76.
    Andrews PI, Ryan MM, Kandt RS: Genetic causes of pediatric stroke. In Genetics of Cerebrovascular Disease. Edited by Alberts MJ. Armonk, NY: Futura Publishing; 1999:261–311. Lucid and comprehensive survey.Google Scholar
  77. 77.
    Mandel H, Brenner B, Berant M, et al.: Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 1996, 334:763–768.PubMedCrossRefGoogle Scholar
  78. 78.
    Perna AF, Castaldo P, De Santo NG, et al.: Homocysteine and chronic renal failure. Miner Electrolyte Metab 1999, 25:279–285.PubMedCrossRefGoogle Scholar
  79. 79.
    Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995, 274:1049–1057.PubMedCrossRefGoogle Scholar
  80. 80.
    Kristensen B, Malm J, Nilsson TK, et al.: Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 1999, 30:974–980.PubMedGoogle Scholar
  81. 81.
    McCully KS: Vascular pathology of homocystinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 1969, 56:111–128.PubMedGoogle Scholar
  82. 82.
    Dudman NP, Wilcken DE, Wang J, et al.: Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993, 13:1253–1260.PubMedGoogle Scholar
  83. 83.
    Kittner SJ, Stern BJ, Feeser BR, et al.: Pregnancy and the risk of stroke. N Engl J Med 1996, 335:768–774.PubMedCrossRefGoogle Scholar
  84. 84.
    Donaldson JO: Cerebrovascular disease. In Neurology of Pregnancy. Edited by Donaldson JO. London: WB Saunders; 1989:137–184.Google Scholar
  85. 85.
    Burkman RT: The estrogen component of OCs: cardiovascular benefits and risks. Int J Fertil 1997, 42(suppl bd1):145–157.Google Scholar
  86. 86.
    Petitti DB, Sidney S, Bernstein A, et al.: Stroke in users of low-dose oral contraceptives. N Engl J Med 1996, 335:8–15.PubMedCrossRefGoogle Scholar
  87. 87.
    Marini C, Totaro R, Carolei A, and National Research Council Group. Long-term prognosis of cerebral ischemia in young adults. Stroke 1999, 30:2320–2325. Defines the actual outcome of stroke in young adults, which is sadly less optimistic than the short-term assessments made in other series.PubMedGoogle Scholar
  88. 88.
    Abram HS, Knepper LE, Warty VS, Painter MJ: Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke. J Child Neurol 1996, 11:276–282.PubMedCrossRefGoogle Scholar
  89. 89.
    Dennis M, Spiegler BJ, Hetherington R: New Survivors for the new millennium: cognitive risk and reserve in adults with childhood brain insults. Brain Cogn 2000, 42:102–105.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Birgitte H. Bendixen
    • 1
  • Jerahme Posner
    • 1
  • Richard Lango
    • 1
  1. 1.Department of NeurologyAlbert Einstein College of MedicineBronxUSA

Personalised recommendations